Effect of salt substitute and antihypertensive medications among high cardiovascular risk patients: A sub‐study of Salt Substitute and Stroke Study (SSaSS)
The Journal of Clinical Hypertension · 2024
DOI: 10.1111/jch.14872 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Hypertension, 2024. Verfasst von Zijing Qi und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Public Health, Shanxi Medical University, Taiyuan, China. Hauptthemen laut MEDLINE: Antihypertensive Agents, Hypertension, Stroke, Blood Pressure. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Health and Medical Research Council of Australia (NHMRC), NHMRC Program, Changzhi Medical College Doctoral Startup Fund.
Themen: Schlaganfall
Abstract (Originalsprache)
The relationship between the differential protective effect of salt substitute between hypertensive and normotensive individuals and the use of cardiovascular medications remains unclear. This study involved 4211 individuals with a history of stroke or hypertension who participated in the Salt Substitute and Stroke Study (SSaSS) from 120 villages in Shanxi Province. The aim of this study was to investigate the differences in major adverse cardiovascular events and blood pressure changes between the salt substitute and the regular salt group in the subgroups of participants taking different antihypertensive medications. Mixed models were employed and adjusted for the cluster effect (village) and potential confounding variables. During the average follow‐up period of 4.66 years, a significantly protective effect of salt substitute on reducing the risk of cardiovascular events was observed in the participants who taking antihypertensive medications (rate ratio: 0.81, 95% CI: 0.68 to 0.95. p = 0.011), whereas no significant effect in participants not taking antihypertensive medications (rate ratio: 0.91, 95% CI: 0.62 to 1.32, p = 0.612). Significant effects to lower systolic blood pressure of the salt substitutes were observed in the participants who took different antihypertensive medications. This study emphasized that the use of salt substitutes might enhance the efficacy of anti‐hypertensive medications in lowering blood pressure and reducing the risk of adverse cardiovascular events.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Public Health, Shanxi Medical University, Taiyuan, China.
- Department of Prevention and Health Care, Affiliated Heping Hospital of Changzhi Medical College, Changzhi, China.
- Department of Public Health and Preventive Medicine, Changzhi Medical College, Changzhi, China.
- School of Medical Board, Shanxi Datong University, Datong, China.
- The George Institute for Global Health, University of New South Wales, Sydney, Australia.
- School of Public Health, Harbin Medical University, Harbin, China.
ORCID-Profile: Zijing Qi
Förderung
- National Health and Medical Research Council of Australia (NHMRC)
- NHMRC Program
- Changzhi Medical College Doctoral Startup Fund
Zitieren
APA
Qi, Z., Tang, S., Hao, Y., Li, Y., Hao, T., Yang, H., Shen, Y., Huang, L., Tian, M., Feng, X., & Li, Z. (2024). Effect of salt substitute and antihypertensive medications among high cardiovascular risk patients: A sub‐study of Salt Substitute and Stroke Study (SSaSS). The Journal of Clinical Hypertension. https://doi.org/10.1111/jch.14872
Vancouver
Qi Z, Tang S, Hao Y, Li Y, Hao T, Yang H, et al. Effect of salt substitute and antihypertensive medications among high cardiovascular risk patients: A sub‐study of Salt Substitute and Stroke Study (SSaSS). The Journal of Clinical Hypertension. 2024. doi:10.1111/jch.14872
BibTeX
@article{Qi2024,
author = {Qi, Zijing and Tang, Shuai and Hao, Yubing and Li, Yanxing and Hao, Tianyou and Yang, Hongmei and Shen, Yijing and Huang, Liping and Tian, Maoyi and Feng, Xiangxian and Li, Zhifang},
title = {Effect of salt substitute and antihypertensive medications among high cardiovascular risk patients: A sub‐study of Salt Substitute and Stroke Study (SSaSS)},
journal = {The Journal of Clinical Hypertension},
year = {2024},
doi = {10.1111/jch.14872}
}
EUVIMED